Stojkovic T, de Seze J, Hurtevent J F, Arndt C, Beaume A, Hache J C, Vermersch P
Department of Neurology, University of Lille, Lille, Cedex, France.
Clin Neurophysiol. 2000 Dec;111(12):2285-91. doi: 10.1016/s1388-2457(00)00478-8.
The frequency of the association between chronic demyelinating inflammatory polyneuropathy (CIDP) and central nervous system (CNS) demyelinating lesions is probably underestimated.
To investigate the occurrence of combined central and peripheral demyelination in CIDP patients and to correlate visual evoked potential (VEP) abnormalities with CNS demyelinating lesions, observed on brain magnetic resonance imaging, and antibodies against glycolipids.
Nerve conduction studies, brain MRI and antibodies against glycolipids were prospectively studied in 17 patients who fulfilled the diagnostic criteria proposed for CIDP (Cornblath DR, Asbury AK, Albers JW, Feasby TE, Hahn AF, McLeod JG, Mendell JR, Parry GJ, Pollard JD, Thomas PK. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology, 1991;41:617-618). VEPs were performed in each case before and after 6 months treatment with either intravenous immunoglobulins (IVIG) or steroids.
Eight patients (47%) had increased latencies in at least one eye or showed increased interocular latency difference. Four patients (23%) presented a significant high signal intensity on T2-weighted brain MRI images. Of these 4 patients, 3 had prolonged VEP latency. Two patients with delayed VEP latency had antibodies against GM1, and SGLPG and anti-sulfatides, respectively. One patient with normal VEPs also had antibodies to GM1. VEP results were not significantly modified after treatment, either with steroids or IVIG.
This study confirmed the high frequency of abnormal VEPs in CIDP patients, and found that they are poorly correlated with CNS demyelinating lesions and antibodies against glycolipids. The VEP abnormalities of these patients may be explained by the susceptibility to immune-mediated damage of both the peripheral nervous system and the optic nerve.
慢性脱髓鞘性炎性多发性神经病(CIDP)与中枢神经系统(CNS)脱髓鞘病变之间关联的频率可能被低估了。
调查CIDP患者中枢和周围联合脱髓鞘的发生情况,并将视觉诱发电位(VEP)异常与脑磁共振成像观察到的CNS脱髓鞘病变以及抗糖脂抗体相关联。
对17例符合CIDP诊断标准(Cornblath DR、Asbury AK、Albers JW、Feasby TE、Hahn AF、McLeod JG、Mendell JR、Parry GJ、Pollard JD、Thomas PK。美国神经病学学会艾滋病工作组特设小组委员会。慢性炎性脱髓鞘性多发性神经病的研究诊断标准。《神经病学》,1991年;41:617 - 618)的患者进行前瞻性神经传导研究、脑MRI及抗糖脂抗体检测。在每例患者接受静脉注射免疫球蛋白(IVIG)或类固醇治疗6个月前后均进行VEP检测。
8例患者(47%)至少一只眼的潜伏期延长或双眼间潜伏期差异增大。4例患者(23%)在T2加权脑MRI图像上出现明显高信号强度。在这4例患者中,3例VEP潜伏期延长。2例VEP潜伏期延迟的患者分别有抗GM1、SGLPG和抗硫脂抗体。1例VEP正常的患者也有抗GM1抗体。使用类固醇或IVIG治疗后,VEP结果无明显改变。
本研究证实了CIDP患者中VEP异常的高频率,并发现其与CNS脱髓鞘病变及抗糖脂抗体相关性较差。这些患者的VEP异常可能是由于外周神经系统和视神经对免疫介导损伤的易感性所致。